Hyperkalemia
📧 Sign up to get email alerts when something new happens for Hyperkalemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Comparison of Potassium Binders in the ER [Phase 4]
Phase 4 trial comparing oral potassium binders for acute hyperkalemia in the emergency department has been terminated. Results have been pos…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Observational Study on the Prevalence and Risk Factors of Patients With Hyperkalaemia in Brazil
An observational study sponsored by AstraZeneca in Brazil will assess the prevalence and risk factors of hyperkalemia among patients and is …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia [Phase 3]
An open-label Phase 3 trial assessing the safety and efficacy of SZC (sodium zirconium cyclosilicate) in pediatric patients with hyperkalemi…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects [Phase 3]
Phase 3 trial evaluating the efficacy and safety of patiromer in Chinese subjects has completed, assessing its efficacy and safety for hyper…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study [Phase 4]
A Phase 4 trial comparing alternate dosing of spironolactone versus finerenone to evaluate safety in patients with elevated potassium relate…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited Potassium Content in Patients With Chronic Kidney Disease: A Pilot Study [NA]
A pilot clinical trial compares the safety of a higher-potassium plant-based diet to a lower-potassium version in patients with advanced chr…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Prediction of Hyperkalemia in Dialysis Patients Through Waveform Analysis Using Wearable ECG
This clinical trial update reports on predicting hyperkalemia in dialysis patients by analyzing wearable ECG waveform data and indicates the…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age [Phase 2]
A Phase 2 clinical trial evaluating patiromer for treatment of hyperkalemia in children under 12 is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Hyperkalemia Quality Improvement Program (HK-QIP) Study [NA]
AstraZeneca-sponsored Hyperkalemia Quality Improvement Program study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Adding Urea to the Final Dialysis Fluid [Phase 1, Phase 2]
Clinical trial update from UCSF on a Phase 1/2 study investigating adding urea to the final dialysis fluid; recruitment is currently ongoing…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Potassium Supplementation in CKD [NA]
This clinical trial update indicates an active-not-recruiting study at Erasmus Medical Center evaluating potassium supplementation in chroni…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Dietary Potassium Liberalization in Pre-Dialysis Patients [NA]
A clinical trial investigating liberalized dietary potassium in pre-dialysis patients with chronic kidney disease and hyperkalemia, currentl…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia [Phase 3]
A Phase 3 trial evaluating the effect of sodium zirconium cyclosilicate on CKD progression in participants with chronic kidney disease and h…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: A National, Multicenter, Prospective, Observational Study to Assess Patient Characteristics, Treatment Algorithms and Disease Management of Hyperkalaemia Patients With Chronic Kidney Disease or Under Dialysis or With Heart Failure, Treated With Sodium Zirconium Cyclosilicate in Greece
A completed national multicenter observational study in Greece assessing patient characteristics, treatment patterns, and management of hype…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: AI-Enabled ECG Stratification and Timing of Potassium-Lowering Therapy in Patients With Hyperkalemia: A Target Trial Emulation Study [NA]
A target trial emulation study evaluating AI-enabled ECG stratification to guide the timing of potassium-lowering therapy in patients with h…
-
CLINICAL_TRIALS withdrawal · 2025-12-23Clinical Trial Update: IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors
The clinical trial evaluating the impact of hyperkalemia on therapy with renin-angiotensin-aldosterone system inhibitors has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: 5 Versus 10 Units of Insulin in Hyperkalemia Management [Phase 4]
A Phase 4 trial comparing 5 units versus 10 units of insulin for the management of hyperkalemia has completed.
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Potassium Correction for RAAS Optimization in Chronic Kidney Disease [Phase 4]
This clinical trial update announces a Phase 4 study evaluating potassium correction to optimize RAAS function in chronic kidney disease, wi…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Evidence for Potassium Restriction in Hemodialysis [NA]
Clinical trial update examining evidence for restricting potassium in patients on hemodialysis; the study is currently active but not recrui…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Nurse-Led Nutritional Education for Moroccan Dialysis Patients [NA]
A completed clinical trial evaluated nurse-led nutritional education for Moroccan dialysis patients with chronic kidney disease and hyperkal…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study [Phase 4]
A Phase 4 trial evaluating continuing sodium zirconium cyclosilicate after discharge in patients with hyperkalemia and chronic kidney diseas…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Two-Part, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of Hyperkalemia [Phase 3]
A two-part Phase 3 clinical trial evaluating WS016 for hyperkalemia is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: AK+ Guard™ Pilot Study in Chronic Kidney Disease: Outpatient Diagnostic Accuracy and Remote Monitoring
A pilot clinical trial evaluating AK+ Guard for outpatient diagnostic accuracy and remote monitoring in hyperkalemia and chronic kidney dise…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Patiromer and Diet/hrQoL in Chronic Dialysis [Phase 3]
A Phase 3 trial is evaluating patiromer combined with dietary intervention for managing hyperkalemia and improving health-related quality of…
-
EMA approval · 2025-09-03EMA Authorised: Lokelma (sodium zirconium cyclosilicate) — AstraZeneca AB
The EMA authorised Lokelma (sodium zirconium cyclosilicate) from AstraZeneca AB for the treatment of hyperkalemia in the European Union.